The trajectory of Viagra presents a intricate picture for investors. While the initial release generated massive returns, the end of its intellectual property protection opened the floodgates to off-brand alternatives, https://bookmarkspy.com/story23250757/the-copyright-and-big-pharma-a-risky-opportunity